baber/WOPTO huggingface dataset:
Patent JP-2847116-B2 (JP)
IPC: A01D34/66
Filed: 1990-11-26
Granted: 1999-01-13
Abstract: The present invention relates to a mower comprising a group of working members (19) extending transversely to the direction of advance (12) during work. It is notable in that: 
 
  a) each driving member (145, 146) comprises a bevel gear (159, 160, 162, 163); 
  b) each central carrier member (133, 134) is connected rigidly to the corresponding bevel-gear housing (145, 146); and 
  c) the two central carrier members (133, 134) are directly and/or indirectly connected rigidly to one another. 
 
<IMAGE>
Patent JP-4364373-B2 (JP)
IPC: G06F17/00
Filed: 1999-12-06
Granted: 2009-11-18
Abstract: PROBLEM TO BE SOLVED: To provide a facial shape classifying device capable of performing the classifying work of facial shape types move easily than in the conventional practice. SOLUTION: In this facial shape classifying device, a CPU displays a contrast image where a facial shape sheet on which a face to be a reference face image is drawn over the face image of the user of the facial shape classifying device to be a comparison face image with the central position of each pair of eyes adjusted and overlapped. The CPU further displays questions on the contrast image. When the user inputs answers to the questions, the CPU classifies the facial type of the comparison face image on the basis of the inputted answers and displays results.
Patent JP-3157174-B2 (JP)
IPC: C07D261/08
Filed: 1990-12-26
Granted: 2001-04-16
Abstract: Piperidinyl, pyrrolidinyl, azepinyl and piperazinyl pyridazines of formula <CHEM>  wherein X represents CH or N; R<1> represents hydrogen, C1-4alkyl, halo, hydroxy, trifluoromethyl, cyano, C1-4alkyloxy, C1-4alkylthio, C1-4alkylsulfinyl, C1-4alkylsulfonyl, C1-4alkyloxycarbonyl, C1-4alkylcarbonyl or aryl; R<2> and R<3> represent hydrogen or C1-4alkyl; Alk represents C1-4alkanediyl;  R<4> and R<5> represent hydrogen, C1-4alkyl or halo; and  Het represents <CHEM> the addition salts and stereochemically isomeric forms thereof, said compounds having antipicornaviral activity. Pharmaceutical compositions containing these compounds as active ingredient, and methods of preparing said compounds and pharmaceutical compositions.
Patent JP-H0261257-B2 (JP)
IPC: A61F13/02
Filed: 1983-04-08
Abstract: A surgical dressing is described which consists essentially of a film which carries an adhesive layer for securing the dressing to the body characterised in that (a) the film is continuous and comprises a polymer which in contact with water has a higher MVP than when in contact with moisture vapour but not water (b) the adhesive layer is adapted to allow access of water to the film when water is in contact with the adhesive layer so that (c) said surgical dressing has a MVP of not less than 2500g/m<2> when the adhesive layer is in contact with water and has a MVP of not more than 2000g/m<2> when the adhesive is in contact with moisture vapour but not water; whereby the dressing is suitable for use on exuding wounds and on non-exuding wounds.
Patent JP-3229316-B2 (JP)
IPC: B65H85/00
Filed: 1990-11-30
Granted: 2001-11-19
Abstract: A device (10) for dispensing sheet media comprising a storage location (34) for storing sheet media to be dispensed; a receiving location (32) accessible to a patron from which the sheet media may be received; a receptacle (122) for retaining sheets of the media; a stacking assembly (200) for stacking individual sheets of the sheet media into a stack; a transport assembly (80), (180) for transporting individual sheets from the storage location (34) to the stacking assembly (200) and for transporting sheets of the media from the receiving location (32) to the receptacle (122); a transfer assembly (400) for transferring a stack of sheets from the stacking assembly (200) to the receiving location (32); and, a divert assembly (300) associated with the transport assembly operable to cause sheets transported from the storage location (34) to the stacking assembly (200) to be diverted to the receptacle (122).
Patent JP-S6145714-B2 (JP)
IPC: C25B11/08
Filed: 1980-10-14
Abstract: A catalytic electrode has an electrically conductive substrate such as titanium with a coating comprising a platinum-group metal catalyst finely dispersed in a matrix consisting of a semi-conducting polymer formed in situ on the substrate. The catalyst may be a platinum-group metal oxide such as iridium oxide formed in situ together with the semi-conducting polymer by the application of a uniform liquid mixture followed by a controlled heat treatment. 
<??>The semi-conducting polymer is preferably formed from polyacrylonitrile, polybenzimidazo-pyrrolone or an adamantane based polybenzoxazole.
Patent JP-H0323063-B2 (JP)
IPC: A61F13/02
Filed: 1985-06-13
Abstract: PCT No. PCT/FR85/00148 Sec. 371 Date Feb. 24, 1986 Sec. 102(e) Date Feb. 24, 1986 PCT Filed Jun. 13, 1985 PCT Pub. No. WO86/00220 PCT Pub. Date Jan. 16, 1986.The present invention relates to an adhesive dressing 1, coated on one surface with a pressure-sensitive adhesive 3 and covered with a non-adhesive support 4. The dressing 1 is folded back on itself on the side of the protective support 4 along a transverse fold 5, to give two parts 1a and 1b. The protective support 4a of one of the two parts 1a is cut along a line 6 parallel to the fold 5. Area 7 of the support between the cut 6 and the fold 5 is provided with an adhesive 8 such that the said area 7 adheres more strongly to the corresponding area of the other part of the support 4b than to the plastic film 2. This invention facilitates application of the dressing to skin.
Patent JP-3827713-B2 (JP)
IPC: A61K38/37
Filed: 1994-03-31
Granted: 2006-09-27
Abstract: PCT No. PCT/SE94/00297 Sec. 371 Date Dec. 21, 1995 Sec. 102(e) Date Dec. 21, 1995 PCT Filed Mar. 31, 1994 PCT Pub. No. WO95/01804 PCT Pub. Date Jan. 19, 1995A pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration comprising recombinant coagulation factor VIII and use thereof for manufacture of a medicament for treating haemophilia is provided. The formulation comprises a highly purified recombinant coagulation factor VIII in a concentration of at least 1000 IU/ml, which gives surprisingly high levels of active factor VIII in the blood stream after subcutaneous, intramuscular or intradermal administration. The formulation is intended for treatment of haemophilia by subcutaneous, intramuscular or intradermal administration. The recombinant factor VIII is preferably a deletion derivative thereof, which can be used for the manufacture of a medicament for subcutaneous administration.
Patent JP-3193728-B2 (JP)
IPC: C12Q1/56
Filed: 1998-06-16
Granted: 2001-07-30
Abstract: The present invention relates to a method of determining the enzymatic activity of blood coagulation factor XIII by using purified fibrin monomer as a substrate of this enzyme. The enzymatic activity is determined by detecting the degree of cross-linking of fibrin monomer formed by the blood coagulation factor XIII and the fibrin monomer free of blood coagulation factor XIII is obtained by washing the preparation with citric acid solution. The present method can be effectively used for the validation of the other enzymatic assay methods for the blood coagulation factor XIII as well as the studies for the characterization of the blood coagulation factor XIII.
Patent JP-3011770-B2 (JP)
IPC: A61K9/00
Filed: 1995-06-21
Granted: 2000-02-21
Abstract: A pharmaceutical formulation for administration by inhalation, a micronized active compound or micronized active compound mixture with a mean particle size of 0.1 mum to 10 mum being applied to a pharmaceutically acceptable excipient having a mean particle size of 200 mum to 1000 mum without the use of binders.
Patent JP-2846460-B2 (JP)
IPC: C08G63/82
Filed: 1990-04-10
Granted: 1999-01-13
Abstract: This invention relates to a method of preparing poly(ethylene 2,6-naphthalene dicarboxylate) by the polycondensation reaction of ethylene glycol and dimethyl-2,6-naphthalene dicarboxylate, using a dimethyl-2,6-naphthalene dicarboxylate starting material which contains significant amounts of methyl hydrogen 2,6-naphthalene dicarboxylate as a contaminant. The methyl hydrogen 2,6-naphthalene dicarboxylate moiety is incorporated into the polymer structure by initially esterifying the methyl hydrogen 2,6-naphthalene dicarboxylate acid end-group with ethylene carbonate, in the presence of an amine or ammonium catalyst, before the polyesterification/polycondensation reaction is performed.
Patent JP-2544268-B2 (JP)
IPC: A23L27/00
Filed: 1991-03-14
Granted: 1996-10-16
Abstract: A proteinaceous emulsion and method for making a proteinaceous emulsion comprising a lipophilic phase, an aqueous phase and a protein emulsifier; which is capable of forming a thin film and has the capability of carrying active ingredients contained in either or both the aqueous phase and the lipophilic phase of the emulsion.
Patent JP-3132757-B2 (JP)
IPC: B66C13/22
Filed: 1992-04-10
Granted: 2001-02-05
Abstract: The object of the invention is a method of controlling a crane or a similar apparatus, utilized e.g. in controlling an overhead crane, wherein the crane attendant applies velocity request (Vref) from the control system of the crane to the operating means of the crane as control sequences and the velocity requests (Vref) applied by the attendant are read into the control system. To improve controllability of the crane, the velocity request (Vref) is compared to the previous velocity request and if the velocity request has changed, an accelerating sequence for the corresponding change in velocity is provided, subsequently storing the resultant accelerating sequence, whereafter, or if the velocity request remains unchanged, the changes in velocity determined by the stored accelerating sequences at a given time are added up and this sum (dV) is added to the previous velocity request (Vref), the resultant sum providing a new velocity request (Vref2), which is set as a new control command and velocity request (Vref2) for the operating means of the crane.
Patent JP-2918261-B2 (JP)
IPC: G09G1/00
Filed: 1989-08-10
Granted: 1999-07-12
Abstract: A time-varying control signal is developed by a current sensor (68) connecting the imaging screen (22) and a closely proximate screen grid (52) of a cathode ray tube as an imaging electron beam is operatively swept across the screen to produce images thereon. The control signal is processed and then applied to at least one of the tube operating elements - such as the horizontal and vertical deflection coils, the focussing lens (14) and, in a plural beam tube, the convergence assembly (50) - which controls a characteristics affecting the quality of an image.
Patent JP-4252626-B2 (JP)
IPC: G05B11/36
Filed: 1997-07-30
Granted: 2009-04-08
Abstract: A wall mountable control panel for controlling power levels delivered to electrical loads, such as lighting loads defining zones, has a zone select switch for scrolling through multiple zones, so as to permit a single control unit (having a power level adjustment switch and a power level display for one zone) in the control panel to be used to separately adjust the power level for, and separately display the power level of, more than one zone. The control panel is capable of controlling M times N zones, where N is the number of control units in the control panel, and where M represents the number of selections that can be made by the zone select switch.
Patent JP-3188449-B2 (JP)
IPC: A61B10/02
Filed: 1990-06-28
Granted: 2001-07-16
Abstract: One-handed operable biopsy needle instruments, employing combined spring driven stylets, and cannulas, capable of taking multiple specimens while the other hand is free, e.g. to manipulate an ultrasound probe are described. The particular biopsy needle instrument shown in detail has a pair of cannula and stylet compression springs, a pair of members directly engaged on the ends of the springs mounting respectively the cannula and stylet, and releasable holding means for holding the springs compressed until firing. The device that loads the stylet spring and a pivotal latch each can serve as a means for releasably holding the stylet spring. A latch is employed to releasably hold the cannula spring. Actuation of the stylet can cause sequential operation of the cannula through impact of the stylet-mounting member on the cannula latch. Finger-displaceable means provided on a side surface of the housing for selective loading of the springs, and provision of finger-displaceable lock and firing button, all operable by a hand while that hand holds the device, enables single-handed loading and taking of the biopsy specimen(s). The embodiment shown employs a pair of longitudinally arranged, recessed thumb-actuated slide switches on a broad side of a rectangular cross-section housing, and lock and firing button on top, in pre-arranged relationship to the bevel of the stylet tip.
Patent JP-2818607-B2 (JP)
IPC: C08K5/3472
Filed: 1989-10-24
Granted: 1998-10-30
Abstract: Disclosed are bis-benzotriazolylphenol compounds having the formula   <CHEM>  wherein  R<1> and R<2> each is a 2-benzotriazolyl radical; R<3> and R<4> each is hydrogen, alkyl, aralkyl, alkoxy, aryl, carboxy, alkoxycarbonyl or halogen; and  A is 1,3- or 1,4-phenylene. Also disclosed are synthetic polymeric materials stabilized with one of the above compounds.
Patent JP-3032289-B2 (JP)
IPC: C12N9/10
Filed: 1990-09-06
Granted: 2000-04-10
Abstract: The enzyme has nucleoside dideoxyribosyltransferase- or deoxyribosyltransferase-, kinase-, reductase-, deaminase- and/or polymerase- activity. It is obtainable from prokaryotic and/or eukaryotic cells and esp. cultured from Lactobacillus leichmannii (DSM 20076) which is fermented anaerobically. The biomass is sepd. and pre-purified before being subjected to anionic exchange chromatography. The enzyme-contg. fraction is collected and further purified by affinity chromatography.
Patent JP-2647743-B2 (JP)
IPC: B01D45/12
Filed: 1991-07-31
Granted: 1997-08-27
Abstract: A processor for an exhaust gas in which finely powdered solid pollutants and gaseous atmosphere pollutants exist in mixture, wherein a gas suction port (29a) for sucking an exhaust gas is formed in a funnel (27) tapered downward, jet nozzles (30a, 30b, 30c) for jetting a compressed gas along the inner wall of the funnel (27) are disposed in the proximity of the gas suction port (29a) and an exhaust port (27a) is formed at a lower part of the funnel (27). <IMAGE>
Patent JP-3265505-B2 (JP)
IPC: D05B3/22
Filed: 1998-11-23
Granted: 2002-03-11
Abstract: A device for feeding buttons to a sewing position. The device centers the buttons and adjusts the width and height of a button feeding passage in accordance with the dimension of the buttons to be conveyed by a conveyor belt, thus appropriately arranging the buttons on garments at the sewing position. The device has two movable guide beds defining a button guide channel. A height adjusting unit is provided above the button guide channel and is vertically moved relative to the channel in accordance with the dimension of the buttons, thus adjusting the height of the channel. A width adjusting unit is operated in conjunction with the two guide beds so as to adjust the width of the channel in accordance with a width of the buttons. A centering unit is operated in conjunction with the width adjusting unit so as to center each of the conveyed buttons at an outlet of the channel. A rotatable feeding unit is arranged to be rotatable between the outlet of the channel and the sewing position, thus feeding the centered buttons from the outlet of the channel to the sewing position.
Patent JP-2547311-B2 (JP)
IPC: G01N21/3577
Filed: 1993-03-25
Granted: 1996-10-23
Abstract: The concentration of urea in a concentration range of 0-0.1% in a milk sample containing at least 1% fat, at least 1% dissolved lactose, and at least 1% protein, is determined with an accuracy better than 0.007%, expressed as Standard Error of Prediction, by an infrared attenuation measuring technique, by determining, on the sample, the attenuation in the region of infrared radiation from 1000 cm-1 (10.0  mu m) to 4000 cm-1 (2.50  mu m), at least one determination being made in a waveband in the region from 1000 cm-1 (10.0  mu m) to 1800 cm-1 (5.56  mu m) in which urea absorbs, at least one other determination being made in a waveband in which fat absorbs, at least one further determination being made in a waveband where lactose absorbs, and at least one further determination being made in a waveband where protein absorbs; determining, on the basis of the thus determined attenuations and predetermined parameters established by multivariate calibration, the contribution from fat, lactose, and protein in the waveband where urea absorbs, and quantitatively assessing the concentration of urea in the sample on the basis of the absorption in the waveband where urea absorbs, and on the basis of the determined contribution from fat, lactose and protein in said waveband. The multivariate calibration may be performed by a Partial Least Squares algorithm, Principal Component Regression, Multiple Linear Regression, or Artificial Neural Network learning. Using the method according to the invention, compensation for the influence on the urea measurement may further be performed for one or several of the following components: citric acid, free fatty acids, antibiotics, phosphates, somatic cells, bacteria, preservatives and casein.
Patent JP-4319252-B2 (JP)
IPC: C07D503/08
Filed: 1996-11-14
Granted: 2009-08-26
Abstract: PCT No. PCT/EP96/05015 Sec. 371 Date May 11, 1998 Sec. 102(e) Date May 11, 1998 PCT Filed Nov. 14, 1996 PCT Pub. No. WO97/18216 PCT Pub. Date May 22, 1997Process for the production of alkali salts of clavulanic acid of formula by conversion of clavulanic acid into a pharmaceutically acceptable salt of clavulanic acid which is characterised in that the conversion is carried out in n-butanol or iso-butanol (2-methyl-1-propanol) as a solvent; and a potassium salt of clavulanic acid containing n-butanol or iso-butanol.
Patent JP-3708549-B2 (JP)
IPC: C07C209/48
Filed: 1995-12-22
Granted: 2005-10-19
Abstract: The invention concerns the simultaneous preparation of caprolactam and hexamethylene diamine from adipodinitrile, by the following steps: (a) the adipodinitrile is partially hydrogenated, producing a mixture substantially containing 6-aminocapronitrile, hexamethylene diamine, ammonia, adipodinitrile and hexamethylene imine (= "the mixture"); (b) the mixture obtained in step (a) is distilled, producing ammonia, as the forerunnings, and a residue I, in the presence of a compound A which is inert in the distillation conditions, the ammonia not being separated totally; (c) the residue I, substantially containing "the mixture", inert compound A and ammonia, the ammonia content being less than that of the mixture used in step (b), is subjected to a second distillation, producing a mixture of the inert compound A and ammonia, as the forerunnings, and a residue II; (d) the base II, substantially containing "the mixture" and inert compound A, is subjected to distillation in a third column, producing the inert compound A, as the forerunnings, and a residue III; (e) the base III, substantially containing "the mixture" and optionally an inert compound B, is subjected to distillation in a fourth column, producing forerunnings KP1, which substantially contain hexamethylene imine, optionally inert compound B and hexamethylene diamine, and a residue IV; (f) the forerunnings KP1 are subjected in a fifth column to distillation, producing forerunnings KP2, which substantially contain hexamethylene imine and optionally inert compound B, and a residue V, which substantially contains hexamethylene diamine with a degree of purity of at least 95 %, the forerunnings KP2 being fed to the third column or optionally only partially fed to the third column, and the rest being discarded; and (g) the residue IV, substantially containing 6-aminocapronitrile and adipodinitrile, is subjected in a sixth column to distillation, producing 6-aminocapronitrile with a degree of purity of at least 95 %, as forerunnings, and adiponitrile in the residue. The resultant 6-aminocapronitrile is cyclized to form caprolactam.
Patent JP-3717936-B2 (JP)
IPC: B01L3/00
Filed: 1996-03-13
Granted: 2005-11-16
Abstract: PCT No. PCT/AU96/00135 Sec. 371 Date Nov. 26, 1997 Sec. 102(e) Date Nov. 26, 1997 PCT Filed Mar. 13, 1996 PCT Pub. No. WO96/28715 PCT Pub. Date Sep. 19, 1996A sample collection device (10), particularly for use in collection of faecal samples for occult blood detection, comprises a collection member having at least one absorbent matrix (12) thereon, and a protective cover member (14) for the collection member, the protective cover member being adapted to receive and shield at least the or each absorbent matrix of the collection member when the collection member is assembled therewith.
Patent JP-3848684-B2 (JP)
IPC: G06F21/12
Filed: 1996-03-22
Granted: 2006-11-22
Abstract: A method and a device for managing a computer network, especially a technique for ensuring the security of a network. A computer network system in which computers are connected to each other through transmission lines, each computer stores the data which constitutes a moving type software exclusively used for security and transmitted together with a message when the computer transmits the message to another computer of the system, and executes the moving type software by using the stored data upon receiving a message from another computer. <IMAGE>
Patent JP-4087906-B2 (JP)
IPC: A61B17/12
Filed: 1998-02-06
Granted: 2008-05-21
Abstract: A closure device for percutaneously forming a closure of a puncture in the tissue of human body. The device comprises a flexible elongate tubular member having proximal and distal extremities and a longitudinal axis. The flexible elongate tubular member has a first lumen extending from the proximal extremity to the distal extremity. A closure assembly is carried by the distal extremity of the flexible elongate tubular member and is movable between contracted and expanded positions. The closure assembly includes a closure mechanism covered by an impermeable membrane. A handle is carried by the proximal extremity of the flexible elongate tubular member and is adapted to be grasped by the human hand. A deployment mechanism is carried by the handle and extends through the flexible elongate tubular member and is coupled to the closure assembly for moving the closure assembly from the contracted position to the expanded position.
Patent PL-161470-B2 (PL)
IPC: B60K17/08
Filed: 1989-04-24
Abstract: espół przeniesienia napędu kierowanego koła
pojazdu trójkołowego, w którym koło kierowane jest
jednocześnie napędzane, znamienny tym, że w dzielonej
obudowie (1) na sześciu osiach (2) osadzonych
jest sześć kół zębatych (3), które oprócz uzębienia
obwodowego posiadają boczne stożkowe uzębienie
(9), a jedno z tych kół jest napędzane wałkiem napędowym
(4) poprzez stożkowe uzębienie (9), zaś zęby
obwodowe kół (3) napędzają środkowe koło zębate (8)
z uzębieniem (10) o zarysie promieniowym w
płaszczyźnie równoległej do osi koła zębatego (8)
przy czym koło (8) osadzone jest na osi (7) w widelcu
(6) połączonym z obrotnicą (5).